Imatinib Mesylate Tablet, Film Coated
Product Images NDC 82009-086

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 82009-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Imatinib Fig1)

FDA Label Image

Imatinib-fig2 (Imatinib Fig2)

FDA Label Image

Figure (Imatinib Fig3)

FDA Label Image

Figure (Imatinib Fig4)

FDA Label Image

Figure (Imatinib Fig5)

Figure 5 shows the overall survival rate in Study 2 for the ITT population. The graph displays the percentage of survival over time, with the x-axis representing survival time in months. The data points indicate different time points of observation. The hazard ratio is given as 0.45, with a p-value of 0.0187. The graph also includes the number of censored observations at different time points. Overall, the survival rate decreases over time.*

FDA Label Image

Package Label-principal Display Panel (100 mg)

FDA Label Image

Package Label-principal Display Panel (400 mg)

FDA Label Image

Chemical Structure (Imatinib Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.